Greenwood Capital Associates’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-3,770
Closed -$219K – 203
2017
Q2
$219K Buy
3,770
+41
+1% +$2.38K 0.06% 175
2017
Q1
$218K Buy
3,729
+89
+2% +$5.05K 0.06% 179
2016
Q4
$202K Buy
+3,640
New +$195K 0.06% 175

Other funds holding ALKS

Greenwood Capital Associates's ALKS Position: Q3 2017 in Review

Greenwood Capital Associates sold out of Alkermes (ALKS) in Q3 2017, closing a stake of 3,770 shares — an estimated $219K sold.

Greenwood Capital Associates first reported a position in ALKS in Q4 2016 and held it in 3 quarters. The position peaked at $219K in Q2 2017. 244 funds tracked by Wall St. Rank hold ALKS as of Q3 2017.

  • Greenwood Capital Associates reported no remaining Alkermes position as of Q3 2017 after selling out during the quarter.
  • Greenwood Capital Associates sold 3,770 Alkermes shares in Q3 2017, an estimated $219K.
  • Greenwood Capital Associates first reported a position in Alkermes in Q4 2016 and held it in 3 quarters.
  • Greenwood Capital Associates's Alkermes position peaked at $219K in Q2 2017.
  • 244 funds tracked by Wall St. Rank held Alkermes as of Q3 2017.

Based on Greenwood Capital Associates's 13F filing for Q3 2017, filed 3 Nov 2017.